Schistosome Syntenin Partially Protects Vaccinated Mice against Schistosoma mansoni Infection
Schistosomiasis affects more than 200 million people worldwide and causes up to 280,000 deaths per year. In terms of global mortality and morbidity, this disease is the most important human helminth infection. Current control strategies are based on chemotherapy, but recurrent re-infection of people...
Main Authors: | Figueiredo, Barbara C., Assis, Natan R. G., Morais, Suellen B., Ricci, Natasha D., Pinheiro, Carina S., Martins, Vicente P., Bicalho, Rodrigo M., Da'dara, Akram A., Skelly, Patrick J., Oliveira, Sergio C. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140676/ |
Similar Items
-
Schistosomes Enhance Plasminogen Activation: The Role of Tegumental Enolase
by: Figueiredo, Barbara C., et al.
Published: (2015) -
Sm10.3, a Member of the Micro-Exon Gene 4 (MEG-4) Family, Induces Erythrocyte Agglutination In Vitro and Partially Protects Vaccinated Mice against Schistosoma mansoni Infection
by: Martins, Vicente P., et al.
Published: (2014) -
Schistosome Feeding and Regurgitation
by: Skelly, Patrick J., et al.
Published: (2014) -
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
by: Gonçalves de Assis, Natan Raimundo, et al.
Published: (2015) -
Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development
by: Figueiredo, Barbara Castro-Pimentel, et al.
Published: (2015)